Pragmatic compulsory licensing policy is needed to enable India to look after health of its people as it cannot afford monopoly in healthcare with the challenges it faces, Cipla's Y K Hamied said.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

"The government should draw up a list of essential, vital medicines that country requires and should put them under compulsory licensing," Cipla's Non-Executive Chairman Y K Hamied told

(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)